This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Qiuping Wang
Introduction: Qiuping Wang is a notable inventor based in Hamden, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target resistant neoplasms. Her work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Latest Patents: Qiuping Wang holds a patent for "Tricyclic compounds as MRP1-inhibitors." This invention relates to compounds of formula I, wherein A is olefin, diol, or acetonide. These compounds are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1. She has 1 patent to her name, showcasing her innovative approach to addressing complex medical challenges.
Career Highlights: Qiuping Wang is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly allows her to collaborate with other talented professionals in the industry, contributing to groundbreaking research and development.
Collaborations: Some of her notable coworkers include Sreenivasarao Vepachedu and Peter Ambrose Lander. These collaborations enhance the innovative environment in which she works, fostering creativity and the exchange of ideas.
Conclusion: Qiuping Wang's contributions to the field of pharmaceuticals exemplify the impact of innovation in medicine. Her work on MRP1-inhibitors is a testament to her dedication to improving patient outcomes and advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile